<html><head></head><body><h1>Anusol HC Suppository</h1><p class="drug-subtitle"><b>Generic Name:</b> hydrocortisone acetate<br/></p><p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.</p><ul>
<li>Description</li>
<li>Clinical Pharmacology</li>
<li>Indications and Usage</li>
<li>Contraindications</li>
<li>Precautions</li>
<li>Patient Counseling Information</li>
<li>Adverse Reactions/Side Effects</li>
<li class="ddc-toggle-hidden">Drug Abuse and Dependence</li>
<li class="ddc-toggle-hidden">Overdosage</li>
<li class="ddc-toggle-hidden">Dosage and Administration</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
</ul><h2>Anusol HC Suppository Description</h2><p class="First">Each Anusol-HC<span class="Sup">™</span> 25 mg Suppository contains 25 mg hydrocortisone acetate in a hydrogenated vegetable oil base. Hydrocortisone acetate is a corticosteroid. Chemically, hydrocortisone acetate is pregn-4-ene-3, 20-dione, 21-(acetyloxy)-11, 17-dihydroxy (11ß)- with the following structural formula:</p><p> </p><h2>Anusol HC Suppository - Clinical Pharmacology</h2><p class="First">In normal subjects, about 26 percent of hydrocortisone acetate is absorbed when the hydrocortisone acetate suppository is applied to the rectum. Absorption of hydrocortisone acetate may vary across abraded or inflamed surfaces.</p><p>Topical steroids are primarily effective because of their anti-inflammatory, anti-pruritic and vasoconstrictive action.</p><h2>Indications and Usage for Anusol HC Suppository</h2><p class="First">For use in inflamed hemorrhoids, post-irradiation (factitial) proctitis, as an adjunct in the treatment of chronic ulcerative colitis, cryptitis, other inflammatory conditions of the anorectum, and pruritus ani.</p><h2>CONTRAINDICATION</h2><p class="First"> Anusol-HC<span class="Sup">™</span> suppositories are contraindicated in those patients with a history of hypersensitivity to any of the components.</p><h2>Precautions</h2><p class="First">Do not use unless adequate proctologic examination is made.</p><p>If irritation develops, the product should be discontinued and appropriate therapy instituted.</p><p>In the presence of an infection, the use of an appropriate antifungal or antibacterial agent should be instituted. If a favorable response does not occur promptly, the corticosteroid should be discontinued until the infection has been adequately controlled.</p><p>No long-term studies in animals have been performed to evaluate the carcinogenic potential of corticosteroid suppositories.</p><h2>Information for Patients:</h2><p class="First">Staining of fabric may occur with use of the suppository. Precautionary measures are recommended.</p><h2>Pregnancy:</h2><p class="First">In laboratory animals, topical steroids have been associated with an increase in the incidence of fetal abnormalities when gestating females have been exposed to rather low dosage levels. There are no adequate and well-controlled studies in pregnant women. Anusol-HC<span class="Sup">™</span> suppositories should only be used during pregnancy if the potential benefit justifies the risk of the fetus. Drugs of this class should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time.</p><p><span class="Bold">Nursing Mothers:</span></p><p>It is not known whether this drug is excreted in human milk, and because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Anusol-HC<span class="Sup">™</span> suppositories, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.</p><h2>Adverse Reactions</h2><p class="First">The following local adverse reactions have been reported with corticosteroid suppositories.</p><p><span class="Bold">To report SUSPECTED ADVERSE REACTIONS, contact Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC, at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch</span>.</p><h2>Drug Abuse and Dependence</h2><p class="First">Drug abuse and dependence has not been reported in patients treated with Anusol-HC<span class="Sup">™</span> suppositories.</p><h2>Overdosage</h2><p class="First">If signs and symptoms of systemic overdosage occur, discontinue use.</p><h2>Anusol HC Suppository Dosage and Administration</h2><p class="First"><span class="Emphasis"><span class="Bold">Usual Dosage:</span></span> One suppository in the rectum morning and night for two weeks, in nonspecific proctitis. In more severe cases, one suppository three times daily; or two suppositories twice daily. In factitial proctitis, recommended therapy is six to eight weeks or less, according to response.</p><h2>How is Anusol HC Suppository Supplied</h2><p class="First">Anusol-HC<span class="Sup">™</span> 25 mg Suppositories are white, cylinder shaped, with one end tapered.<br/>
NDC 65649-411-12 25 mg 12 suppositories<br/>
NDC 65649-411-24 25 mg 24 suppositories</p><p><span class="Emphasis"><span class="Bold">Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Store away from heat. PROTECT FROM FREEZING.</span></span></p><p><span class="Bold">Manufactured for</span>: Salix Pharmaceuticals, a division of Valeant</p><p>Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA</p><p>Anusol-HC is a trademark of Valeant Pharmaceuticals International, Inc. or its affiliates.</p><p>© Valeant Pharmaceuticals North America LLC</p><p><span class="Emphasis"><span class="Bold">OPENING INSTRUCTIONS</span></span></p><p><span class="Emphasis"><span class="Bold">Avoid excessive handling of the suppository.</span></span> It is designed to melt at body temperature.</p><p>1. Separate plastic film at top opening and pull downward.</p><p>2. Continue pulling downward to almost the full length of the suppository.</p><p>3. Gently remove the suppository from the film pocket.</p><p>Rev. 10/2017</p><p>9520701</p><p>2201318</p><p>9B500 9L J2</p><p class="First"><span class="Emphasis"><span class="Bold">PACKAGE LABEL PRINCIPAL DISPLAY PANEL - Carton</span></span></p><p><span class="Emphasis"><span class="Bold">NDC </span>65649-411-12</span></p><p><span class="Emphasis"><span class="Bold">Rx only</span></span></p><p><span class="Emphasis"><span class="Bold">Anusol-HC<span class="Sup">™   </span></span></span></p><p><span class="Emphasis"><span class="Bold">(Hydrocortisone Acetate in a</span></span></p><p><span class="Emphasis"><span class="Bold">Hydrogenated Vegetable Oil Base)</span></span></p><p><span class="Bold">For rectal use only.</span></p><p><span class="Bold">Not for oral use.</span></p><p><span class="Emphasis"><span class="Bold">12 Suppositories</span></span></p><h2>More about Anusol-HC Suppositories (hydrocortisone topical)</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>2 Reviews</li>
<li>Drug class: topical steroids</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li>Hydrocortisone in Absorbase &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(FDA)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Anusol-HC cream, ointment, suppository</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Hemorrhoids</li>
<li>Anal Itching</li>
<li>Proctitis</li>
<li>Pruritus</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>